agoraphobia

Search with Google Search with Bing
Information
Disease name
agoraphobia
Disease ID
DOID:593
Description
"A phobic disorder involving the specific anxiety about being in a place or situation where escape is difficult or embarrassing or where help may be unavailable." [url:http\://en.wikipedia.org/wiki/Anxiety_disorder]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05124639 Active, not recruiting N/A Clinical Trial of a Group Self-management Support Program for Anxiety Disorders October 6, 2022 December 21, 2026
NCT03899090 Active, not recruiting N/A Floatation-REST (Reduced Environmental Stimulation Therapy) for Anxiety and Depression April 8, 2019 May 31, 2024
NCT00202709 Completed N/A Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder? May 2002 August 2003
NCT00353470 Completed Phase 3 Comparison of Psychotherapy Programs to Treat Panic Disorder September 2006 September 2012
NCT00576719 Completed Phase 2 Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia March 2005 March 2011
NCT00734370 Completed N/A Virtual Reality Exposure Therapy in Agoraphobic Participants October 2008 January 2012
NCT00932919 Completed N/A Thought Field Therapy and Cognitive Therapy for Agoraphobia October 2006 November 2010
NCT01025908 Completed N/A Cognitive Behavior Psychotherapy in Panic Disorder May 2006 April 2007
NCT03925987 Completed N/A Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide June 7, 2018 July 31, 2020
NCT00004366 Completed N/A Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction August 1995 May 2000
NCT01446172 Completed Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Agoraphobia November 2009 November 2010
NCT01928810 Completed N/A Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia March 2011 February 2014
NCT01928823 Completed Phase 2 Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia November 2011 May 2014
NCT02150265 Completed N/A Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics January 1, 2013 March 1, 2018
NCT02605668 Completed N/A Providing Tools for Effective Care and Treatment of Anxiety Disorders December 12, 2015 July 24, 2019
NCT02810171 Completed N/A Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety December 2016 November 12, 2021
NCT02811458 Completed N/A Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders September 12, 2016 July 10, 2019
NCT02852577 Completed Phase 4 Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine January 2000 August 2012
NCT03051074 Completed N/A Examining the Effects of Reduced Environmental Stimulation on Anxiety December 1, 2016 December 31, 2019
NCT03113175 Completed N/A Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice January 15, 2018 March 29, 2021
NCT03143634 Completed Phase 1/Phase 2 The Modular Protocol for Mental Health (MPMH) July 18, 2017 July 31, 2020
NCT03156556 Completed N/A Improving Access to the Treatment of Anxiety and Depression Among Young Adults May 15, 2017 January 31, 2018
NCT03206437 Completed N/A Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli June 20, 2017 November 25, 2022
NCT03522844 Completed Phase 4 Treatments for Anxiety: Meditation and Escitalopram June 18, 2018 January 5, 2022
NCT03684577 Completed N/A Efficacy of Hypnotherapy for Agoraphobia November 1, 2018 September 29, 2020
NCT03785223 Completed Phase 4 A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity April 20, 2019 October 31, 2022
NCT00000368 Completed Phase 3 Treatment of Panic Disorder: Long Term Strategies February 1999 July 2004
NCT06081348 Not yet recruiting Phase 2 Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders October 2023 April 2024
NCT05118594 Not yet recruiting N/A Testing a Precision Psychotherapy System for Low-income Patients February 2026 November 2026
NCT06315660 Not yet recruiting N/A VR Based Therapy to Treat Anxiety in Dual Diagnosis November 2024 April 2026
NCT03845101 Recruiting N/A CBT Versus CBT With Virtual Reality Exposure for Social Anxiety Disorder and Agoraphobia February 19, 2019 April 9, 2024
NCT02305537 Recruiting N/A Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment October 2014 October 2070
NCT03528109 Recruiting N/A Improving Access to Child Anxiety Treatment July 1, 2018 February 1, 2025
NCT03549819 Recruiting Phase 3 Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study December 15, 2021 February 2024
NCT05671419 Recruiting N/A Mindful Self-Compassion for Anxiety Disorders and Depression January 16, 2022 July 2026
NCT05427708 Recruiting N/A Respiratory Training vs Interoceptive Exposure in the Treatment of Transdiagnostic Pathological Anxiety August 22, 2022 May 2025
NCT05510804 Recruiting N/A Efficacy of an App-based CBT Featuring Virtual Reality for Anxiety Disorders March 3, 2020 March 1, 2023
NCT00182533 Terminated Phase 4 Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders July 2002 January 2018
NCT04695249 Unknown status N/A Using 360° Videos in the Treatment of Anxiety Disorders January 4, 2021 October 31, 2021
NCT03885453 Unknown status Construction of a Questionnaire on Panic Disorder and Agoraphobia March 2019 December 1, 2022
NCT01323556 Unknown status Phase 2/Phase 3 Mechanisms of Panic Disorders Treatment March 2010 May 2012
NCT00129610 Unknown status N/A Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia January 2004
NCT04460378 Unknown status N/A Exposure Initializes Therapy - Treatment Of Homebound Patients Extended January 1, 2018 October 1, 2020
NCT04569760 Withdrawn Phase 3 Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study April 2021 June 2023
Disase is a (Disease Ontology)
DOID:591
Cross Reference ID (Disease Ontology)
ICD10CM:F40.0
Cross Reference ID (Disease Ontology)
MESH:D000379
Cross Reference ID (Disease Ontology)
NCI:C34362
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:154885006
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0001818
Exact Synonym (Disease Ontology)
Fear of open spaces
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0000756
ICD10 preferred id (Insert disease from ICD10)
D0004553
ICD10 class code (Insert disease from ICD10)
F40.0